• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植受者的差异燃料利用及其与非酒精性脂肪性肝病的关系。

Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease.

机构信息

Division of Gastroenterology and Hepatology, Virginia Commonwealth University, Richmond, Virginia, USA.

Division of Gastroenterology and Hepatology, Hunter-Holmes McGuire VA, Richmond, Virginia, USA.

出版信息

Liver Int. 2022 Jun;42(6):1401-1409. doi: 10.1111/liv.15178. Epub 2022 Feb 24.

DOI:10.1111/liv.15178
PMID:35129295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9189602/
Abstract

UNLABELLED

Metabolic flexibility is the ability to match biofuel availability to utilization. Reduced metabolic flexibility, or lower fatty acid (FA) oxidation in the fasted state, is associated with obesity. The present study evaluated metabolic flexibility after liver transplantation (LT).

METHODS

Patients receiving LT for non-alcoholic steatohepatitis (NASH) (n = 35) and non-NASH (n = 10) were enrolled. NASH was chosen as these patients are at the highest risk of metabolic complications. Metabolic flexibility was measured using whole-body calorimetry and expressed as respiratory quotient (RQ), which ranges from 0.7 (pure FA oxidation) to 1.0 is (carbohydrate oxidation).

RESULTS

The two cohorts were similar except for a higher prevalence of obesity and diabetes in the NASH cohort. Post-prandially, RQ increased in both cohorts (i.e. greater carbohydrate utilization) but peak RQ and time at peak RQ was higher in the NASH cohort. Fasting RQ in NASH was significantly higher (0.845 vs. 0.772, p < .001), indicative of impaired FA utilization. In subgroup analysis of the NASH cohort, body mass index but not liver fat content (MRI-PDFF) was an independent predictor of fasting RQ. In NASH, fasting RQ inversely correlated with fat-free muscle volume and directly with visceral adipose tissue.

CONCLUSION

Reduced metabolic flexibility in patients transplanted for NASH cirrhosis may precede the development of non-alcoholic fatty liver disease after LT.

摘要

目的

评估肝移植(LT)后代谢灵活性的变化。

方法

纳入因非酒精性脂肪性肝炎(NASH)(n=35)和非 NASH(n=10)而接受 LT 的患者。选择 NASH 是因为这些患者发生代谢并发症的风险最高。使用全身量热法测量代谢灵活性,并以呼吸商(RQ)表示,RQ 的范围为 0.7(纯脂肪酸氧化)至 1.0 是(碳水化合物氧化)。

结果

两组除 NASH 组肥胖和糖尿病的患病率较高外,其他特征相似。进餐后,两组的 RQ 均增加(即碳水化合物利用率增加),但 NASH 组的峰值 RQ 和达到峰值 RQ 的时间更高。NASH 患者的空腹 RQ 明显更高(0.845 比 0.772,p<0.001),表明脂肪酸利用受损。在 NASH 亚组分析中,体重指数而不是肝脂肪含量(MRI-PDFF)是空腹 RQ 的独立预测因子。在 NASH 中,空腹 RQ 与去脂肌肉量呈负相关,与内脏脂肪组织呈正相关。

结论

NASH 肝硬化患者移植后代谢灵活性降低可能先于 LT 后发生非酒精性脂肪性肝病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/807777b66696/LIV-42-1401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/4a7ccd08a6c0/LIV-42-1401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/613ab5e10a87/LIV-42-1401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/9415a1b0bfa2/LIV-42-1401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/807777b66696/LIV-42-1401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/4a7ccd08a6c0/LIV-42-1401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/613ab5e10a87/LIV-42-1401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/9415a1b0bfa2/LIV-42-1401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4969/9545127/807777b66696/LIV-42-1401-g004.jpg

相似文献

1
Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease.肝移植受者的差异燃料利用及其与非酒精性脂肪性肝病的关系。
Liver Int. 2022 Jun;42(6):1401-1409. doi: 10.1111/liv.15178. Epub 2022 Feb 24.
2
Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients.移植肝受者的代谢灵活性降低可预测体重增加。
Liver Transpl. 2024 Feb 1;30(2):192-199. doi: 10.1097/LVT.0000000000000169. Epub 2023 May 8.
3
Impact of Liver Transplantation on Adipose Tissue Compartments and Its Association With Metabolic Sequela.肝移植对脂肪组织分区的影响及其与代谢后遗症的关联。
Transplantation. 2024 Jan 1;108(1):235-241. doi: 10.1097/TP.0000000000004704. Epub 2023 Jul 12.
4
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.肝移植术后非酒精性脂肪性肝炎肝硬化的转归:与酒精性肝硬化的比较。
Ann Hepatol. 2019 Nov-Dec;18(6):855-861. doi: 10.1016/j.aohep.2019.06.014. Epub 2019 Sep 6.
5
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.性别影响经肝活检证实的非酒精性脂肪性肝病患者四肢骨骼肌与内脏脂肪面积比与非酒精性脂肪性肝炎之间的关联。
Br J Nutr. 2022 Jun 14;127(11):1613-1620. doi: 10.1017/S0007114521002415. Epub 2021 Jun 28.
6
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.非酒精性脂肪性肝炎肝移植的结果:一项欧洲肝移植登记研究。
J Hepatol. 2019 Aug;71(2):313-322. doi: 10.1016/j.jhep.2019.04.011. Epub 2019 May 7.
7
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.隐源性肝硬化(CC)和非酒精性脂肪性肝炎(NASH)肝硬化的肝移植(LT):来自移植受者科学登记处(SRTR)的数据:1994年至2016年。
Medicine (Baltimore). 2018 Aug;97(31):e11518. doi: 10.1097/MD.0000000000011518.
8
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.肝移植后发生的非酒精性脂肪性肝病或非酒精性脂肪性肝炎的代谢机制与治疗。
Nat Rev Endocrinol. 2022 Oct;18(10):638-650. doi: 10.1038/s41574-022-00711-5. Epub 2022 Jul 15.
9
Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝移植术后新发2型糖尿病的风险
BMC Gastroenterol. 2015 Dec 15;15:175. doi: 10.1186/s12876-015-0407-y.
10
Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.非酒精性脂肪性肝病在非酒精性脂肪性肝炎和隐源性肝硬化患者肝移植后的发生:移植前供体脂肪变性的影响。
HPB (Oxford). 2020 Apr;22(4):521-528. doi: 10.1016/j.hpb.2019.07.015. Epub 2019 Aug 17.

引用本文的文献

1
Liver transplant recipients have worse metabolic body phenotype compared with matched non-transplant controls.与匹配的非移植对照组相比,肝移植受者具有更差的代谢身体表型。
JGH Open. 2024 Sep 24;8(9):e70024. doi: 10.1002/jgh3.70024. eCollection 2024 Sep.
2
Unlocking metabolic flexibility: Is this the key to preventing weight gain in liver transplant recipients?解锁代谢灵活性:这是预防肝移植受者体重增加的关键吗?
Liver Transpl. 2024 Feb 1;30(2):119-121. doi: 10.1097/LVT.0000000000000224. Epub 2023 Jul 25.

本文引用的文献

1
Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients.振动控制瞬时弹性成像在肝移植受者中的诊断性能。
Clin Gastroenterol Hepatol. 2021 Feb;19(2):367-374. doi: 10.1016/j.cgh.2020.03.067. Epub 2020 Apr 6.
2
On the Definition of Sarcopenia in the Presence of Aging and Obesity-Initial Results from UK Biobank.在衰老和肥胖存在的情况下肌少症的定义-来自英国生物库的初步结果。
J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1309-1316. doi: 10.1093/gerona/glz229.
3
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
肝移植受者脂联素水平降低与心血管事件的关系。
Transplantation. 2019 Nov;103(11):2323-2328. doi: 10.1097/TP.0000000000002714.
4
Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients.小而密的低密度脂蛋白胆固醇可预测肝移植受者的心血管事件。
Hepatology. 2019 Jul;70(1):98-107. doi: 10.1002/hep.30518. Epub 2019 Mar 29.
5
Body Composition Profiling in the UK Biobank Imaging Study.英国生物库影像研究中的身体成分分析。
Obesity (Silver Spring). 2018 Nov;26(11):1785-1795. doi: 10.1002/oby.22210. Epub 2018 May 22.
6
Improving temporal accuracy of human metabolic chambers for dynamic metabolic studies.提高人类代谢室进行动态代谢研究的时间准确性。
PLoS One. 2018 Apr 24;13(4):e0193467. doi: 10.1371/journal.pone.0193467. eCollection 2018.
7
Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.失代偿期患者行肝移植评估时的冠状动脉疾病。
Liver Transpl. 2018 Mar;24(3):333-342. doi: 10.1002/lt.25012.
8
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science.非酒精性脂肪性肝炎临床试验终点纳入和分析的定义:从监管科学的角度。
Hepatology. 2018 May;67(5):2001-2012. doi: 10.1002/hep.29607. Epub 2018 Feb 22.
9
Metabolic Flexibility in Health and Disease.健康与疾病中的代谢灵活性
Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015.
10
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.非酒精性脂肪性肝炎相关肝硬化患者肝移植后的长期预后
Transplantation. 2017 Aug;101(8):1867-1874. doi: 10.1097/TP.0000000000001709.